USPTO serial 79292460
MABXMISE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 23, 2021
- Examiner
- SALCIDO, JOHN CHARLES
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MABXMISE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebeccah Gan
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science, biochemical catalysts, biochemical reagents used for non-medical purposes, biochemical preparations for scientific purposes, biological preparations for use in industry and science; proteins for industrial use, in raw materials form for scientific and medical research; diagnostic preparations used in science; diagnostic reagents and preparations, except for medical or veterinary use; immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry | ACTIVE | — |
| 005 | Medicated skin care preparations; medicated skin care preparations for veterinary use; diagnostic preparations for veterinary purposes, chemical reagents for medical or veterinary purposes, proteins for medical or veterinary use, namely, protein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids | ACTIVE | — |
| 041 | Educational services, namely, providing tutorial sessions, panel discussions, non-downloadable webinars, seminars, and training in the fields of pharmaceuticals and biotechnology; publishing of books, manuals, magazines, and computer data intended for use on a computer or telephone network; electronic publishing services, namely, publication of text and graphic works of others on CD-ROMs in the fields of pharmaceuticals and biotechnology; organizing and conducting colloquiums, conferences and congresses in the fields of pharmaceuticals and biotechnology for educational purposes; organization of exhibitions for cultural or educational purposes; organization of events for cultural purposes; organizing events in the fields of pharmaceuticals and biotechnology for educational purposes | ACTIVE | — |
| 042 | Scientific and industrial research in the fields of chemistry, biochemistry, biotechnology and biology; computer programming, and design, development, rental, updating and maintenance of software; engineering services in the nature of the provision of expert reports in the field of chemistry, biochemistry, biotechnologies and biology; technical advice, consultation and information all in the fields of biochemistry, biotechnologies and biology, namely, technical support and advice for drawing up, developing and implementing protein chemistry, protein biochemistry, biotechnologies and protein biology methods, protocols, and procedures; material testing, namely, testing of chemical, biochemical, biotechnology and biological materials and substances; research services in the chemical, biochemical, biotechnological and biological fields provided in laboratories; therapeutic strategies research and development services, namely, research and development in the pharmaceutical and biotechnology fields | ACTIVE | — |
| 044 | Medical services; veterinary services; medical analysis services in relation to the treatment of individuals, namely, x-ray examinations for medical purposes, medical testing of blood, medical testing of urine, blood, hair follicles and breath, medical imaging services, medical testing for diagnostic or treatment purposes; DNA screening for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PROMISE PROTEOMICS
- Other trademarks owned by PROMISE PROTEOMICS
- Other trademarks owned by PROMISE PROTEOMICS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MABXMISE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 23, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 27, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 27, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 27, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 27, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 16, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 2, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 2, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 23, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 1, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 1, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 1, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 1, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 30, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 29, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 28, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |